Lone Pine Capital 13F: New $296M Stake in McKesson (MCK)

Lone Pine Capital Takes New Position in McKesson

Investment firm Lone Pine Capital opened a brand-new stake in McKesson Corporation (NYSE:MCK), picking up 392,224 shares during the period. According to its Form 13F filing with the SEC for the period ending May 15, 2026, the newly initiated position carried an estimated value of $296.4 million based on the reported cost basis. Because this is a fresh holding for the fund, there is no prior share count or percentage comparison to report.

McKesson Stock Performance and Valuation

McKesson shares recently changed hands at $755.60. The medical distributor trades in a 52-week range between $714.00 and $999.00. Its current share price sits below both its 50-day moving average of $868.28 and its 200-day moving average of $844.44. The company has a price-to-earnings ratio of 23.79 and a forward P/E ratio of 17.56, backed by a market capitalization of roughly $103.35 billion.

Recent Insider Transaction Activity

Chief Executive Officer Brian Tyler sold 8,463 shares of company stock on June 17, 2026. The shares were sold at an average price of $775.13 for a total transaction value of about $6.56 million. The trade was carried out under a pre-arranged Rule 10b5-1 trading plan.

Analysts Set New Price Targets

Wall Street analysts maintain a generally favorable view of the company, holding a consensus buy recommendation. On October 16, 2026, UBS maintained a buy rating while lifting its price target to $1200.00 from $1080.00. Leerink Partners maintained an outperform rating with a $1070.00 target on October 7, 2026. Earlier, RBC Capital reiterated its sector perform rating at a target of $845.00 on September 14, 2026, and Barclays maintained an overweight rating with a $1000.00 target on August 19, 2026.

Dividend Payments

McKesson distributes an annual dividend of $3.76 per share, yielding 0.43%. The company maintains a dividend payout ratio of 0.088, which shows that a small fraction of its earnings goes toward shareholder payouts.

Overview of McKesson Corporation

Headquartered in Irving, Texas, McKesson operates as a healthcare services company. It distributes pharmaceutical drugs, medical-surgical supplies, and health technology solutions across four main business segments. The company connects pharmacies, hospitals, manufacturers, and patients to streamline healthcare delivery and medication access.

What to Watch at McKesson Corporation

Investors will look toward McKesson's next earnings report scheduled for November 4, 2026, for updates on revenue growth and profit margins. Because 13F filings look backward at holdings from a prior date, these disclosures reflect past portfolio choices and may not match the investor's current holdings today.